Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eurax Hc cream
1304000V0BTABAJ
|
Eurax-Hydrocortisone | Hydrocortisone | Skin | 1,766 |
|
Eucerin Dry Skin Relief 5% face cream
1302010U0BGAEAK
|
Eucerin | Urea | Skin | 1,755 |
|
Betamethasone dipropionate 0.05% cream
1304000D0AAAAAA
|
Betamethasone esters | Betamethasone esters | Skin | 1,752 |
|
White soft paraffin solid
1302010N0AAAAAA
|
Paraffin Soft white | Paraffin soft white | Skin | 1,745 |
|
Loceryl 5% medicated nail lacquer
1310020A0BBAAAA
|
Loceryl | Amorolfine hydrochloride | Skin | 1,709 |
|
Dimeticone 22% / Benzalkonium chloride 0.1% cream
1302020D0AAACAC
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | 1,706 |
|
Locoid 0.1% cream
1304000W0BBAAAA
|
Locoid | Hydrocortisone butyrate | Skin | 1,692 |
|
Synalar 1 in 4 Dilution 0.00625% ointment
1304000N0BBAHBC
|
Synalar | Fluocinolone acetonide | Skin | 1,675 |
|
Nystatin 100,000units/g/Chlorhex Hcl 1% / Hydrocort 0.5% crm
1304000V0AACFCF
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 1,651 |
|
Fluocinolone acetonide 0.025% ointment
1304000N0AABBBB
|
Fluocinolone acetonide | Fluocinolone acetonide | Skin | 1,650 |
|
Urea 10% / Lactic acid 5% cream
1302010U0AAAEAE
|
Urea (Emollient) | Urea | Skin | 1,647 |
|
Betamethasone dipropionate 0.05% ointment
1304000D0AABABA
|
Betamethasone esters | Betamethasone esters | Skin | 1,633 |
|
Tretinoin 0.025% / Erythromycin 4% solution
1306010I0AAAFAF
|
Erythromycin (Topical) | Erythromycin | Skin | 1,629 |
|
Audavate 0.1% ointment
1304000F0BGABBA
|
Audavate | Betamethasone valerate | Skin | 1,579 |
|
Hydrocortisone butyrate 0.1% cream
1304000W0AAAAAA
|
Hydrocortisone butyrate | Hydrocortisone butyrate | Skin | 1,570 |
|
Menthoderm 2% cream
1303000AABFACAC
|
Menthoderm | Menthol | Skin | 1,520 |
|
Veil cover cream
130802000BBBIA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 1,515 |
|
Terra-Cortril ointment (Intrapharm)
1304000V0CCAFCM
|
Terra-Cortril (Topical) | Hydrocortisone | Skin | 1,514 |
|
Bettamousse 0.1% cutaneous foam
1304000F0BEAABF
|
Bettamousse | Betamethasone valerate | Skin | 1,500 |
|
Acnecide Wash 5% gel
1306010C0BUACAB
|
Acnecide | Benzoyl peroxide | Skin | 1,499 |
|
Clobetasol 500microg/Neomycin 5mg/Nystatin 100,000unit/g crm
1304000G0AACACA
|
Clobetasol propionate | Clobetasol propionate | Skin | 1,487 |
|
Titanium ointment
130202000AAAZAZ
|
Generic compound preparation BNF 1302020 | Other barrier preparations | Skin | 1,472 |
|
Permethrin 1% scalp application
1310040Q0AAAAAA
|
Permethrin | Permethrin | Skin | 1,440 |
|
Acitretin 10mg capsules
1305020A0AAABAB
|
Acitretin | Acitretin | Skin | 1,423 |
|
Isotretinoin 10mg capsules
1306020J0AAACAC
|
Isotretinoin (Systemic) | Isotretinoin | Skin | 1,388 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.